A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
Clinical trial NCT05763121 · TERMINATED
Trial details
- NCT number
- NCT05763121
- Sponsor
- Areteia Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-12-08
- Enrollment
- 1061
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.